Based on the Zhongchao Inc stock forecast from 0 analysts, the average analyst target price for Zhongchao Inc is not available over the next 12 months. Zhongchao Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Zhongchao Inc is Bearish, which is based on 3 positive signals and 8 negative signals. At the last closing, Zhongchao Inc’s stock price was USD 1.25. Zhongchao Inc’s stock price has changed by -2.34% over the past week, -37.19% over the past month and -86.84% over the last year.
No recent analyst target price found for Zhongchao Inc
No recent average analyst rating found for Zhongchao Inc
Company Overview Zhongchao Inc
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers patient management services in the tumor and rare diseases field; internet healthcare services, and pharmaceutical services, as well as operates an online information platform. It also provides online and onsite health information services, healthcare education programs, and healthcare training products, including clinical practice training, open classes of popular medical topics, interactive case studies, academic conference and workshops, continuing education courses, and articles and short videos with educational healthcare content, as well as sells patent drugs. The company offers its services through its MDMOOC online platform, including MDMOOC mobile App, MOOC Medical WeChat subscription account, and MDMOOC website; and patient management services through IT system under the Zhongxun brand, WeChat mini program, and Zhongxin Health WeChat mini program. It serves enterprises, non-for-profit organizations, and medical journals, as well as healthcare professionals, nurses, doctors, and other healthcare workers. The company was founded in 2012 and is headquartered in Shanghai, China. Read Less
Zhongchao Inc. provides healthcare information, education, and training services in the People's Republic of China. The company offers patient management services in the tumor and rare diseases field; internet healthcare services, and pharmaceutical services, as well as operates ...Read More
Frequently Asked Questions About Zhongchao Inc (ZCMD) Stock
Stock Target Advisor's fundamental analysis for Zhongchao Inc's stock is Bearish.
Unfortunately we do not have enough data on ZCMD's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ZCMD's stock to indicate what its average analyst target is.
ZCMD stock's Price/Earning ratio is 110.63.
Our analysis grades ZCMD stock's Price / Earning ratio at F. This means that ZCMD stock's Price/Earning ratio is above 68% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this ZCMD may be a overvalued for its sector.
The last closing price of ZCMD's stock was USD 1.25.
The most recent market capitalization for ZCMD is USD 7.30M.
Unfortunately we do not have enough analyst data on ZCMD's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Zhongchao Inc's stock.
As per our most recent records Zhongchao Inc has 142 Employees.
Zhongchao Inc's registered address is Nanxi Creative Center, Shanghai, China, 200040.
You can get more information about it from Zhongchao Inc's website at https://www.izcmd.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Underpriced compared to book value
The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Zhongchao Inc (ZCMD) Stock
Stock Target Advisor's fundamental analysis for Zhongchao Inc's stock is Bearish.
Unfortunately we do not have enough data on ZCMD's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on ZCMD's stock to indicate what its average analyst target is.
ZCMD stock's Price/Earning ratio is 110.63.
Our analysis grades ZCMD stock's Price / Earning ratio at F. This means that ZCMD stock's Price/Earning ratio is above 68% of the stocks in the Health Information Services sector in the NSD exchange.
Based on this ZCMD may be a overvalued for its sector.
The last closing price of ZCMD's stock was USD 1.25.
The most recent market capitalization for ZCMD is USD 7.30M.
Unfortunately we do not have enough analyst data on ZCMD's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Zhongchao Inc's stock.
As per our most recent records Zhongchao Inc has 142 Employees.
Zhongchao Inc's registered address is Nanxi Creative Center, Shanghai, China, 200040.
You can get more information about it from Zhongchao Inc's website at https://www.izcmd.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ZCMD !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
